sales@ambeed.com

Structure Search

List Search MOL Search Structure Search

Hello, Sign in

Home Cart 0 Sign in

[ CAS No. 158171-14-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

2D 3D

Chemical Structure| 158171-14-3

Chemical Structure| 158171-14-3

Structure of 158171-14-3 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 158171-14-3 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 158171-14-3 ]

SDS Specification

Alternatived Products of [ 158171-14-3 ]

Product Details of [ 158171-14-3 ]

CAS No. :	158171-14-3	MDL No. :	MFCD00797869
Formula :	C₂₅H₂₄NO₈P	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	ZBPUWGDUVAAWJY-QHCPKHFHSA-N
M.W :	497.43	Pubchem ID :	11005563
Synonyms :

Calculated chemistry of [ 158171-14-3 ]

Physicochemical Properties

Num. heavy atoms :	35
Num. arom. heavy atoms :	18
Fraction Csp3 :	0.2
Num. rotatable bonds :	12
Num. H-bond acceptors :	8.0
Num. H-bond donors :	3.0
Molar Refractivity :	126.46
TPSA :	141.2 Å²

Pharmacokinetics

GI absorption :	Low
BBB permeant :	No
P-gp substrate :	Yes
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	Yes
CYP2D6 inhibitor :	Yes
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-7.25 cm/s

Lipophilicity

Log Po/w (iLOGP) :	5.15
Log Po/w (XLOGP3) :	2.94
Log Po/w (WLOGP) :	4.16
Log Po/w (MLOGP) :	2.01
Log Po/w (SILICOS-IT) :	2.79
Consensus Log Po/w :	3.41

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	2.0
Egan :	1.0
Muegge :	0.0
Bioavailability Score :	0.56

Water Solubility

Log S (ESOL) :	-4.36
Solubility :	0.0215 mg/ml ; 0.0000432 mol/l
Class :	Moderately soluble
Log S (Ali) :	-5.57
Solubility :	0.00135 mg/ml ; 0.00000271 mol/l
Class :	Moderately soluble
Log S (SILICOS-IT) :	-6.6
Solubility :	0.000125 mg/ml ; 0.000000252 mol/l
Class :	Poorly soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	1.0 alert
Leadlikeness :	2.0
Synthetic accessibility :	4.83

Safety of [ 158171-14-3 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 158171-14-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 158171-14-3 ]
Downstream synthetic route of [ 158171-14-3 ]

[ 158171-14-3 ] Synthesis Path-Upstream 1~7

1
[ 100-51-6 ]
[ 158171-14-3 ]

Reference： [1] Organic Letters, 2012, vol. 14, # 5, p. 1206 - 1209
[2] Patent: WO2013/12416, 2013, A1,
[3] Patent: WO2013/12846, 2013, A1,

2
[ 175291-54-0 ]
[ 158171-14-3 ]

Reference： [1] Bulletin of the Chemical Society of Japan, 1996, vol. 69, # 2, p. 465 - 468
[2] Chemistry Letters, 1994, # 6, p. 1099 - 1102

3
[ 76101-29-6 ]
[ 158171-14-3 ]

Reference： [1] Organic Letters, 2012, vol. 14, # 5, p. 1206 - 1209
[2] Patent: WO2013/12846, 2013, A1,

4
[ 125760-26-1 ]
[ 158171-14-3 ]

Reference： [1] Bulletin of the Chemical Society of Japan, 1996, vol. 69, # 2, p. 465 - 468
[2] Chemistry Letters, 1994, # 6, p. 1099 - 1102

5
[ 108549-21-9 ]
[ 158171-14-3 ]

Reference： [1] Bulletin of the Chemical Society of Japan, 1996, vol. 69, # 2, p. 465 - 468
[2] Chemistry Letters, 1994, # 6, p. 1099 - 1102

6
[ 73724-45-5 ]
[ 158171-14-3 ]

Reference： [1] Bulletin of the Chemical Society of Japan, 1996, vol. 69, # 2, p. 465 - 468
[2] Chemistry Letters, 1994, # 6, p. 1099 - 1102

7
[ 158171-13-2 ]
[ 158171-14-3 ]

Reference： [1] Bulletin of the Chemical Society of Japan, 1996, vol. 69, # 2, p. 465 - 468
[2] Chemistry Letters, 1994, # 6, p. 1099 - 1102

[ 158171-14-3 ] Synthesis Path-Downstream 1~7

1
[ 29022-11-5 ]
[ 158171-14-3 ]
[ 92557-81-8 ]
2,5-dioxo-1-pyrrolidinyl 4-[(1E)-2-[4-(dimethylamino)phenyl]diazenyl]-benzoate [ No CAS ]
C₇₅H₉₀N₁₄O₂₉P₂S [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	Multistep reaction;

Reference： [1]Pellois, Jean-Philippe; Hahn, Michael E.; Muir, Tom W. [Journal of the American Chemical Society, 2004, vol. 126, # 23, p. 7170 - 7171]

2
[ 71989-26-9 ]
[ 71989-28-1 ]
[ 158171-14-3 ]
[ 175281-76-2 ]
Fmoc-Ser(t-Bu)OHFmoc-Cys(Trt)-OH [ No CAS ]
C₃₆H₆₁N₉O₂₁P₂S₂ [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2004,vol. 126,p. 7170 - 7171

3
[ 29022-11-5 ]
[ 1019331-83-9 ]
[ 71989-31-6 ]
[ 35661-40-6 ]
[ 108-24-7 ]
[ 146982-24-3 ]
[ 158171-14-3 ]
[ 143824-78-6 ]
Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
[ 1400869-94-4 ]

Reference： [1]Chemical Communications,2012,vol. 48,p. 9534 - 9536

4
[ 158171-14-3 ]
[ 407-41-0 ]

Yield	Reaction Conditions	Operation in experiment
60%		Commercially available Fmoc-Ser(HPO3Bn)-OH (200 mg, 0.4 mmol) was dissolved in a mixture of 20% diethylamine in DMF (2 mL) and stirred for two hours at room temperature. The solvent was then removed under reduced pressure. The mixture was then dissolved in methanol (2 mL), 10% Pd/C (10 mg) was added and the reaction was left to stir overnight with H2 gas bubbling into the mixture. The suspension was then filtered through on Celite and the solvent evaporated under reduced pressure. After suspension in water (3 mL), the suspension was washed with diethyl ether (2×3 mL) and ethyl acetate (2×3 mL). The aqueous phase was collected and the water evaporated under reduced pressure. The resulting residue was recrystallised from a mixture of water, cold diethyl ether and methanol to afford 112 (44 mg, 60%) as a white powder. IR vmax (neat) 3002 (br), 1629, 1516, 1088, 987, 760; 111 NMR (300 MHz, D2O) delta 4.18-4.06 (2H, m, H(3), 3.94-3.91 (1H, m, Hbeta); m/z (ESI) 184.00 [M-H]-, 369.01 [M2-H]-. The 1H NMR, IR and MS data obtained were in agreement with that reported in the literature (Arnold, L. D. et al. J. Am. Chem. Soc. 1988, 110, 2237-2241).

Reference： [1]Patent: US2013/29920,2013,A1 .Location in patent: Paragraph 0700

5
[ 29022-11-5 ]
[ 68858-20-8 ]
[ 71989-31-6 ]
[ 35661-40-6 ]
[ 158171-14-3 ]
[ 146987-10-2 ]
C₄₉H₇₁N₁₁O₁₃PPolS [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2014,vol. 53,p. 8421 - 8426
Angew. Chem.,2014,vol. 126,p. 8561 - 8566

6
[ 29022-11-5 ]
[ 71989-31-6 ]
[ 57-10-3 ]
[ 158171-14-3 ]
[ 175291-56-2 ]
(S)-6-[(Diphenyl-p-tolyl-methyl)-amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid [ No CAS ]
Fmoc-Arg(pg) [ No CAS ]
Fmoc-Ser(pg) [ No CAS ]
Fmoc-Tyr(pg) [ No CAS ]
H-K(Pal)-K(Pal)-GYSSPGS(p)PGT(p)PGSRSR-K(Pal)-K(Pal)-NH₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
		2.5: Synthesis of peptide antigen T9 The orthogonally protected amino acid Fmoc-Lys(Mtt)-OH (3 eq) was manually loaded to an amide resin (Rink amide MBHA resin, 1 eq, 0.4 mmol) in the presence of PyBOP/HOBt/DIEA in DMF. The resin was then washed with DMF (3 x 1 min). After removing the N-terminal Fmoc group with 25% piperidine in DMF (1 x 1 min and 2 x 15 min), the second residue of Fmoc-Lys(Mtt)-OH (3 eq), was coupled using the same loading conditions. The following 16 amino acids bearing the Fmoc standard side-chain protecting groups were incorporated applying the previously described coupling protocol. The phosphoaminoacids were introduced as monobenzyl esters at the phosphate group. The coupling time was determined by TNBT test or chloranyl test after a Proline. If necessary, a second coupling was performed with 2 eq of Fmoc-aminoacid in the presence of DIC/HOBt or HATU/DIEA. Each coupling step was followed by a wash step with DMF (3 x 1 min), Fmoc removal step with 25% piperidine in DMF (1 x 1 min and 2 x 15 min) and a second wash step with DMF (7 x 1 min). After the coupling of the Thr(PO(OBzI)OH), 0.5% DBU in DMF was used for the Fmoc-deprotection step. The assembly of the peptide sequence finished with the addition of the last two Fmoc-Lys(Mtt)-OH. Then, the Mtt-groups of the terminal lysine residues were selectively cleaved by treatment of the resin (1 eq, 650 mg, 0.156 mmol) with 10 mL of TtPS/TFA/DCM (1:1:98) during several cycles of 10 min. After washing with DCM (x3) and DMF (x3), Palmitic acid (20 eq, 1.01 g, 3.15 mmol) was coupled to those deprotected amino groups using TBTU (20 eq, 814 mg, 3.15 mmol) and DIEA (40 eq, 1.1 mL, 6.30 mmol) in DCM/DMF (1:1) (6 mL). The resin was washed thoroughly with DCM (x5) and DMF (x5). Then the N-terminal Fmoc group was removed with 20% piperidine in DMF (3 x 10 min) and the resin was washed again with DMF (x3) and DCM (x5). Finally simultaneous resin cleavage and side-chain deprotections were carried out using a mixture of TFA/TIPS/H2O (95:2.5:2.5) (9 mL) during 3 h. Trituration from cold diethyl ether gave the crude product T9 as a white solid (291 mg, 59% yield) with a purity of 69% (from HPLC analysis). MALDI-TOF mass spectrometry confirmed the identity of the major product (m/z expected: 3172.98 [MH+], found: 3172.90).

Reference： [1]Patent: EP2413957,2016,B1 .Location in patent: Paragraph 0221

7
[ 68858-20-8 ]
[ 35661-39-3 ]
[ 71989-31-6 ]
[ 158171-14-3 ]
[ 175291-56-2 ]
Fmoc-Gln(pg)-OH [ No CAS ]
Fmoc-Glu(pg)-OH [ No CAS ]
Fmoc-Lys(pg)-OH [ No CAS ]
Fmoc-Asp(pg)-OH [ No CAS ]
Fmoc-Cys(pg)-OH [ No CAS ]
CDDEApSpTpTVpSKpTEpTpSQVAPA, pT-Thr(phospho), pS-Ser(phospho) [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
		General procedure: Solid Phase Peptide Synthesis. Solid phase peptide synthesis was performed using a CEM-Discover Microwave assisted Peptide Synthesizer (CEM Corporation, Mathews, N.C.) using the Fmoc strategy. The maximum temperature for couplings was set at 75 C. with 25 W. The Phosphorylated peptides were synthesized typically on 0.1 mmol scale. (0149) Coupling procedure for protocol 1 (MW-SPPS): Fmoc-protected amino acid (5 equivalents), 4.5 equivalents HATU and DIPEA (8 equivalents) were dissolved in DMF (6 mL). The mixture was allowed to activate for 5 min at 0 C. then added to the resin bearing free amine. The reaction mixture was then microwave-irradiated for 5 min at 75 C. The resin was allowed to cool to room temperature and then washed thoroughly with DMF. All the Fmoc deprotections were performed by treating the peptidyl-resin twice with 20% piperidine in DMF for 2 min and 4 min at 75 C. temperature, both using MW irradiation. The solid support was then washed thoroughly with DMF. (0150) Coupling procedure for protocol 2 (pSPPS): Fmoc-protected amino acid (3 equivalents), 2.5 equivalents HATU and DIPEA (6 equivalents) were dissolved in DMF(3mL). The mixture was allowed to activate for 5 min at 0 C. then added to the resin bound peptide. The solid support was then microwave-irradiated for 5 min at 75 C. The resin was allowed to cool to room temperature then washed thoroughly with DMF. All the Fmoc deprotections were performed by treating the peptidyl-resin twice with 20% piperidine in DMF for 10 min and 15 min at room temperature without the use of MW. The solid support was then washed thoroughly with DMF. All the non-phosphorylatedamino acids were coupled using 5 equivalents of amino acids, 4.5 equivalents of HATU and 8 equivalents of DIPEA in 6 mLof DMF employing conditions from protocol 2. (0151) Coupling procedure for protocol 3 (ET-pSPPS): Fmoc-protected amino acid (3 equivalents), 2.5 equivalents HATU and DIPEA (6 equivalents) were dissolved in DMF (3 mL). The mixture was allowed to activate for 5 min at 0 C. and treated with the resin bearing free amine. The solid support was then microwave-irradiated for 10 min at 75 C. The resin was allowed to cool to room temperature then washed thoroughly with DMF. All Fmoc deprotections were performed by treating the peptidyl-resin twice with 20% piperidine in DMF for 10 min and 15 min at room temperature without the use of MW. The solid support was then washed thoroughly with DMF. All the non-phosphorylated amino acids were coupled using 5 equivalents of amino acids, 4.5 equivalents of HATU and 8 equivalents of DIPEA in 6 mL of DMF employing the above conditions. (0152) Coupling procedure for protocol 4 (DC-pSPPS): Fmoc-protected amino acid (3 equivalents), 2.5 equivalents HATU and DIPEA (6 equivalents) were dissolved in DMF (3 mL). The mixture was activated at 0 C. for 5 min. The activated amino acid solution was then added to the resin bound peptide. The double coupling was performed at 75 C. for 5 min each time using 3equivalents of fresh phosphorylated amino acid in each cycle. The resin was washed thoroughly with DMF and the completion of coupling was checked by Kaiser test and HPLC-MS analysis performed after cleavage from the solid support. All the Fmoc deprotections were performed by treating the peptidyl-resin twice with 20% piperidine in DMF for 10 min and 15 min at room temperature without the use of MW. The solid support was then washed thoroughly with DMF. All the non-phosphorylated amino acids were coupled using 5 equivalents of amino acids, 4.5 equivalents of HATU and 8 equivalents of DIPEA in 6 mL of DMF employing the conditions from protocol 4. (0153) Coupling procedure for protocol 5 (EBB-pSPPS): Fmoc-protected amino acid (5 equivalents), 4.5 equivalents HATU and DIPEA (8 equivalents) were dissolved in DMF(6 ml).The mixture was allowed to activate for 5 min at 0 C. The activated amino acid solution was then added to the resin with free amine. The 10 min coupling was performed in two cycles using 5 equivalents of fresh phosphorylated amino acid in each cycle under microwave-irradiation at 75 C. The resin was allowed to cool to room temperature then washed thoroughly with DMF. The reaction was monitored by Kaiser test. All the Fmoc deprotections were performed by treating the peptidyl resin twice with 20% piperidine in DMF for 10 min and 15 min at room temperature without the use of MW. The solid support was then washed thoroughly with DMF. All the non-phopshorylated amino acid residues were also incorporated employing the same conditions. (0154) Room temperature Fmoc deprotection: The Fmoc-peptidyl-resin was treated twice with 20% piperidine in DMF (6 mL) for 10 min and 15 min at room temperature. The solid support was then washed thoroughly with DMF. (0155) Microwave Fmoc deprotection: The resin bound Fmoc-peptide was treated twice with 20% piperidine in DMF (6 mL) for 2 min and 4 min at 75 C. under microwave irradiation. The resul...

Reference： [1]Patent: US2020/10502,2020,A1 .Location in patent: Paragraph 0034; 0148-0156; 0162

Same Skeleton Products

Related Products

Historical Records

Related Functional Groups of
[ 158171-14-3 ]

Amino Acid Derivatives

[ 175291-56-2 ]

(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((benzyloxy)(hydroxy)phosphoryl)oxy)butanoic acid

Similarity: 0.89

[ 191348-16-0 ]

Fmoc-Tyr(HPO3Bzl)-OH

Similarity: 0.85

[ 73724-45-5 ]

Similarity: 0.79

[ 116861-26-8 ]

Similarity: 0.79

[ 122889-11-6 ]

Fmoc-D-Ser(Bzl)-OH

Similarity: 0.78

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Ghs Hazard Statements

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere